Hyperadrenocorticism (HAC) or Cushing’s syndrome is a challenging, but rewarding disease to diagnose and treat. On average, a vet will diagnose one new case every six months1, making HAC a common canine endocrinopathy.
Vetoryl is rated as ‘Very effective’ or ‘Effective’ by 98% of vets1 – successful treatment will reverse the clinical signs of HAC and help prevent complications seen in untreated cases (including diabetes mellitus, urinary tract infections, urolithiasis, hypertension, pancreatitis and thromboembolic disease2). A reported 94% of dogs remain on Vetoryl treatment, once started, with our client support materials helping to boost compliance and bond clients to your practice1.
By recommending treatment you can be confident that Vetoryl will transform quality of life for dogs and owners – life restored on every level.
REFERENCES
1. Vetoryl 092015
2. Mooney, C. (2009) Hyperadrenocorticism - to treat or not to treat? UK Vet 14 (6), 1-5
Navigation